OpenText Information Management
NOVEMBER 21, 2022
Pharmaceutical organizations in the life sciences industry face challenges in developing and maintaining data integrity due to complex validation documentation. Maintaining data consistency, accuracy, and integrity across many documents is challenging.
Gimmal
FEBRUARY 1, 2024
The new collaboration is off to a great start with its first successfully completed joint solution delivery for a top, leading global pharmaceutical company. NNIT has deep life sciences expertise, specifically within the compliance and validation arena, so we know how important it is to document and keep immaculate records.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AIIM
APRIL 6, 2021
In a truly all-digital world, there would be no need for printers – or scanners or document couriers. Documents would never need to be printed, and processes would run smoothly from all-electronic input to all-electronic output. Just think of how efficiency increases when the paper is removed!
OpenText Information Management
AUGUST 28, 2020
Its integrated scientific solutions necessitate careful documenting of trials, test results, product formulae, manufacturing processes, and more. As a Contract Research and Manufacturing organization with over 330 clients around the globe, regulatory compliance is non-negotiable for Syngene International.
erwin
JULY 2, 2020
He added, “We have also linked it to our documentation repository, so we have a description of our data documents.” They have documented 200 business processes in this way. In particular, the tool helped them to design their qualification review, which is necessary in a pharmaceutical business.
Data Matters
SEPTEMBER 3, 2020
Annuity Suitability Working Group Drafting FAQ Document to Facilitate Uniformity in State Adoption of Revised Suitability in Annuity Transactions Model Regulation. A draft of the FAQ document was exposed for a 30-day comment period to seek feedback regarding whether additional topics should be included in the document.
Data Matters
DECEMBER 4, 2019
Cryptoassets are not documents of title, documentary intangibles or negotiable instruments, nor are they instruments under the UK Bills of Exchange Act nor goods under the UK Sale of Goods Act. Cryptoassets cannot be physically possessed, so they cannot be the object of a bailment, and only some types of security can be granted over them.
Expert insights. Personalized for you.
67 
Let's personalize your content